International Conference on Influenza – 2015

24th August - 25th August 2015 | London, UK
Omics Group Inc.

About Organizer


OMICS group Inc., has organized more than 300 conferences around the world. Our goal is to reach the scientific knowledge to All, through our 400 open access journals from all the leading themes of life science, engineering and technology. International Conference on Influenza – 2015 is organized with the support of the editorial board from the : Journal of Virology and Antiviral Research,  Journal of Infectious Disease and Therapy, and  The Journal of Virology and Mycology.


The gathering in London will provide an opportunity for the researchers to discuss about the various challenges posed by influenza strains. From its seasonal occurrence to global challenges the threat of influenza spread has jeopardized most of our normal life. Researches are along the way for an effective and potent vaccination which is yet to realize its fullest goal. The researchers from Virology, Microbiology, Public health, Immunologists , Physicians, NHS and healthcare will be available to exchange their thoughts and clinical outcomes on treating flu and related variants.

The conference tracks are set to cover various perception of researches involved with flu and control measures.  This would help to accommodate every possible researchers working on flu to help build a vivid picture about this common infectious disease. We will have speakers, poster sessions and workshops designed to represent the talks from experts and students.


B2B & Sponsors


Influenza-2015, London has exhibitor spaces available for product promotion by industrial exhibitors or act as the potential sponsor to introduce products of academia, industrial and field applications. Exhibitor booths are served on First come First serve basis depending on the space availability.  Timely notification to the organizers is highly recommended to make appropriate arrangements.

Please call/e-mail to the event organizers for further details.


  • Molecular virology and immunology
  • Virus host interaction/pathogenesis/transmission
  • Antiviral drug development and treatment strategies, including vaccination
  • Evolution and Epidemiological aspects of Influenza
  • National and international surveillance and contingency strategies
  • Virus as Vectors for human gene therapy
  • Reassortment and Reverse Genetics
  • Implications for pandemic influenza preparedness
  • Strategies for Developing New Antiviral Flu Drugs
  • New Avenues for Influenza Control
  • Advances in viral detection and identification technologies
  • Vaccines: current and novel approaches
  • Clinical impact & diagnostics approaches
  • Animal flu-ecology